Europe Eye Health Supplements Market By Formulation, By Indication, By Ingredient Type, By Country, Industry Analysis and Forecast, 2020 - 2026

The Europe Eye Health Supplements Market is expected to witness market growth of 9.6% CAGR during the forecast period (2020-2026).

A rising preference for tablet formulation as eye health supplements due to their high accessibility in numerous forms like sustained-release tablets, chewable tablets, and sublingual and buccal tablets, and it is contributing to the growth of this segment growth. In addition to it, since tablets are cheaper than other supplement forms and their extensive adoption among patients of all age groups are driving the market growth. Moreover, the high shelf life of tablets than powder and liquid forms is another factor boosting the demand for tablet formulations.

Bilberry extract is one of the major eye health supplements, is widely used to relieve eye fatigue and it is also used for the treatment of many eye disorders such as glaucoma, cataracts, and near-sightedness. The easy and affordable availability of bilberry extract for eye health is one of the major factors driving the use of flavonoids as eye health supplements, this in turn positively impacting the market growth.

Rising cases of myopia are due to increased risk of several progressive eye disorders including glaucoma, cataract, and age-related macular degeneration. Increasing inclination for eye health supplements among the geriatric population and millennials, highly vulnerable to digital eye fatigue and it is further driving the market globally. The rise in prevalence of numerous eye conditions including dry eye syndrome, cataract, Age-related Macular Degeneration (AMD), and inflammation coupled with the increasing recommendation for eye health supplements by ophthalmologists for treatment and prevention of these disorders is further boosting the market.

Based on Formulation, the market is segmented into Tablets, Capsules, Powder, Softgels, and Liquid. Based on Indication, the market is segmented into Age-related Macular Degeneration (AMD), Dry Eye Syndrome, Inflammation, Cataract and Others. Based on Ingredient Type, the market is segmented into Lutein and Zeaxanthin, Antioxidants, Flavonoids, Alpha-Lipoic Acid, Omega-3 Fatty acids, Coenzyme Q10, Astaxanthin and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include The Nature’s Bounty Co. (The Carlyle Group L.P.), Pfizer, Inc., Alticor Inc. (Amway Corporation), Novartis AG, Kemin Industries, Inc., ZeaVision LLC (EyePromise), EyeScience Labs, LLC, Vitabiotics Ltd., Nutrivein and NutraChamps, Inc.

Scope of the Study

Market Segments covered in the Report:

By Formulation

• Tablets
• Capsules
• Powder
• Softgels,
• Liquid

By Indication

• Age-related Macular Degeneration (AMD)
• Dry Eye Syndrome
• Inflammation
• Cataract
• Others

By Ingredient Type

• Lutein and Zeaxanthin
• Antioxidants
• Flavonoids
• Alpha-Lipoic Acid
• Omega-3 Fatty acids
• Coenzyme Q10
• Astaxanthin
• Others

By Country

• Germany
• UK
• France
• Russia
• Spain
• Italy
• Rest of Europe

Companies Profiled

• The Nature’s Bounty Co. (The Carlyle Group L.P.)
• Pfizer, Inc.
• Alticor Inc. (Amway Corporation)
• Novartis AG
• Kemin Industries, Inc.
• ZeaVision LLC (EyePromise)
• EyeScience Labs, LLC
• Vitabiotics Ltd.
• Nutrivein
• NutraChamps, Inc.

Unique Offerings from the Publisher

• Exhaustive coverage
• Highest number of market tables and figures
• Subscription based model available
• Guaranteed best price
• Assured post sales research support with 10% customization free